Overview

Hyoscine Butyl Bromide for Management of Prolonged Labor

Status:
Unknown status
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
To determine the value of using Hyoscine as an antispasmodic drug for the management of prolonged labor in nulliparous women at term.
Phase:
Phase 3
Details
Lead Sponsor:
Ain Shams University
Collaborators:
Armed Forces Hospital, Southern Region, Khamis Mushayt, Saudi Arabia
Armed Forces Hospitals, Southern Region, Saudi Arabia
Treatments:
Bromides
Butylscopolammonium Bromide
Scopolamine
Scopolamine Hydrobromide